AN INSIGHT TO THE SYNTHETICALLY OBTAINED TRIAZOLE POSSESSING NUMEROUS BIOLOGICAL ACTIVITIES

  • Mohammad Arshad CIRBSc, Jamia Millia Islamia, New Delhi 110025, India, Faculty of Unani Medicine, AMU, Aligarh 202002, India.

Abstract

Heterocyclic chemistry is fundamental to biology and medicine. It is not implausible to say that we are living in the age of heterocyclic chemistry. It constitutes a large group of organic molecules exhibiting a wide range of biological activities which is the basis of life and society. The majority of pharmaceutical products that mimic natural products with biological activity are heterocyclic in nature. Azoles, five-membered heterocyclic compounds with two or three nitrogen atoms, constitute a large group of organic substances exhibiting a wide range of biological activities. Triazole, a five-membered azole nucleus composed of three nitrogen atoms and two carbon atom is found to possess enormous biological activity such as anti-HIV, anti-HBV, antibacterial, antitumor, anti-inflammatory, antiviral, CNS stimulant, antifungal and antituberculosis activities. Moreover, triazole nucleus is found in many drugs such as anastrozole, estazolam, ribavirin and triazolam. Here in this review article we have reported the recent development in the pharmacological activity of some newly synthesized triazole derivatives.

 

Keywords: Triazoles, Synthesis biological activity.

Downloads

Download data is not yet available.

Author Biography

Mohammad Arshad, CIRBSc, Jamia Millia Islamia, New Delhi 110025, India, Faculty of Unani Medicine, AMU, Aligarh 202002, India.
I HAVE BEEN AWARDED Ph.D DEGREE IN MEDICINAL CHEMISTRY FROM JAMIA MILLIA ISLAMIA NEW DELHI, AND NOW WORKING AS A RESEARCH ASSOCIATE AT ALIGARH MUSLIM UNIVERSITY

References

1. Lia P, Wang L. One-Pot Synthesis of 1,2,3-Triazoles from benzyl and alkyl halides, sodium azide and alkynes in water under transition-metal-catalyst free reaction conditions. Lett Org Chem 2007;4:23-6.
2. Balabina RM. Tautomeric equilibrium and hydrogen shifts in tetrazole and triazoles: focal-point analysis and ab initio limit. J Chemical Physics 2009;131:154-307.
3. El-Barbary AA, Abou-El-Ezz AZ, Abdel-Kadder AA, El-Daly M, Nielsen C. Synthesis of some new 4-amino-1,2,4-triazole derivatives as potential anti-HIV and anti-HBV. Phosphorus Phosphorus Sulfur Silicon 2004;179:1497-508.
4. El-Sayed R. Synthesis, antibacterial and surface activity of 1,2,4-triazole derivatives. Indian J Chem 2006;45B: 738-46.
5. Varvarason A, Tantili-Kakoulidou A, Siatra-Papastasikoudi T, Tiligada E. Synthesis and biological evaluation of indole containing derivatives of thiosemicarbazide and their cyclic 1, 2, 4-triazole and 1, 3, 4-thiadiazole analogs. Arzneim Forsch 2000;50:48-54.
6. Gokce M, Cakir B, Earl K, M Sahin. Synthesis and antimicrobial activity of [(2-oxabenzothiazolin-3-yl)-methyl]-4-alkyl/aryl-1, 2, 4-triazoline-5-thiones. Arch Pharm 2001;334:279-83.
7. Pintilie O, Profire L, Sunel V, Popa, Pui A. Synthesis and antimicrobial activity of some new 1,3,4-thiadiazole and 1,2,4-triazole compounds having a D,L-methionine moiety. Molecules 2007;12:103-13.
8. XI Z, LH L, GY J, Zhon ZX. Synthesis, fungicide activity and 3D-QSAR of 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles. J Agric Food Chem 2002;50:3757-60.
9. Chem H, Li Z, Han Y. Synthesis and fungicidal activity against Rhizoctonia solani of 2-alkyl(alkylthio)-5-pyrazolyl-1,3,4-oxadiazoles (thiadiazoles). J Agric Food Chem 2000;48:5312-5.
10. Shavarama HB, Narayana PK, Sooryanarayana RB, Shivananda MK. Chem New bis-aminomercapto-triazoles and bis-triazolothi-adiazoles as possible anticancer agents. Eur J Med 2002;37:511-7.
11. Shenone S, Bruno O, Ranise A, Bondavalli W, Falcone G, Giordano L, Vitelli M. 3-Arylsulphonyl-5-arylamino-1, 3, 4-thiadiazol-2(3H) ones as anti-inflammatory and Analgesic agents. Bioorg Med Chem 2001;9:2149-53.
12. Todoulou NG, Papadaki-Valiraki AE, Ikeda S, De Clercq E. Synthesis and antiviral activity of some new 1H-1,2,4-triazole derivatives. Eur J Med Chem 1994;29:611-20.
13. Papakonstantinou-Garoufalia SS, Tani E, Todoulou O, Papadaki-Valiraki A, Filippatos E, De Clercq E, Kourounakis PN. J Pharm Pharmacol 1998;50:117-24.
14. Heindel ND, Reid JR. 4-Amino-3-mercapto-4H-1,2,4-triazoles and propargyl aldehydes: a new route to 3-R-8-aryl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazepines. J Heterocycl Chem 1980;17:1087-8.
15. Shenone S, Bruno O, Ranise A, Bondavalli W, Falcone G, Giordano L, Vitelli M. 3-Arylsulphonyl-5-arylamino-1, 3, 4-thiadiazol-2(3H) ones as anti-inflammatory and Analgesic agents. Bioorg Med Chem 2001;9:2149-53.
16. Özdemir A, Turan-Zitouni G, Kaplancıklı ZA, Chevallet P. Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity. J Enzym Inhib Med Chem 2007;22:511-6.
17. Clemons M, Coleman RE, Verma S. Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?. Cancer Treat Rev 2004;30:325.
18. Serdar M, Gümrükçüoglu N, Alpay Karaoglu S, Demirbas N. Synthesis of Some Novel 3,5-Diaryl-1,2,4-Triazole Derivatives and Investigation of Their Antimicrobial Activities. Terk J Chem 2007;31:315.
19. Alkbarzadeh T, Tabatabai SA, Khoshnoud MJ, Shafaghi B, Shafiee A, Akbarzadeh T, et al. Design and synthesis of 4h-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists. Bioorg Med Chem 2003;11:769-73.
20. Almasirad A, Tabatabai SA, Faizi M, Shafiee A, Almasirad A, Tabatabai SA, et al. Shafiee: synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. Bioorg Med Chem Lett 2004:14:6057-9.
21. Brucato A, Coppola A, Gianguzza S, Provenzano PM. [Triazolam: characteristics of its depressive action]. Boll Soc Ital Biol Sper 1978;54:1051.
22. Balfour HHN Jr. Antiviral drugs. Engl J Med 1999;340:1255.
23. Koparir M, Orek C, Parlak AE, Söylemez A, Koparir P, Karatepe M, Dastan SD. Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones. Eur J Med Chem 2013;63:340-6.
24. Plech T, Luszczki JJ, Wujec M, Flieger J, Pizo M. Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles. Eur J Med Chem 2013;60:208-15.
25. Elamari H, Slimi R, Chabot GG, Quentin L, Scherman D, Girard C. Synthesis and in vitro evaluation of potential anticancer activity of mono-and bis-1,2,3-triazole derivatives of bis-alkynes. Eur J Med Chem 2013;60:360-4.
26. Becker RC, Povsic T, Cohen MG, Rusconi CP, Sullenger B. Nucleic acid aptamers as antithrombotic agents: opportunities in extracellular therapeutics. Thromb Haemostasis 2010;103(3):586-95.
27. Varizhuk AM, Tsvetkov VB, Tatarinova ON, Kaluzhny DN, Florentiev VL, Timofeev EN, et al. Synthesis, characterization and in vitro activity of thrombin-binding DNA aptamers with triazole internucleotide linkages. Eur J Med Chem 2013;67:90-7.
28. Shulman N, Winters M. A review of HIV-1 resistance to the nucleoside and nucleotide inhibitors. Curr Drug Targets Infect Disord 2003;3:273-81.
29. Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2003;2:812-22.
30. Martinez-Picado J, De Pasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, et al. D’ Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000;97:10948-53.
31. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-94.
32. Wu J, Yu W, Fu L, He W, Wang Y, Chai B, Song C, et al. Design, synthesis, and biological evaluation of new 20-deoxy-20-fluoro-40-triazole cytidine nucleosides as potent antiviral agents. Eur J Med Chem 2013;63:739-45.
33. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004;4:24-34.
34. Chinthakindi PK, Sangwan PL, Farooq S, Aleti RR, Kaul A, Saxena AK, et al. Diminutive effect on T and B-cell proliferation of non-cytotoxic a-santonin derived 1,2,3-triazoles: a report. Eur J Med Chem 2013;60:365-75.
35. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. New Engl J Med 1999;340:1888.
36. Dannhardt G, Kiefer W. Cyclooxygenase inhibitors current status and future prospects. Eur J Med Chem 2001;36:109-26.
37. Haider S, Alam MS, Hamid H, Shafi S, Nargotra A, Mahajan P, et al. Synthesis of novel 1,2,3-triazole based Benzoxazolinones: their TNF-α based Molecular Docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation. Eur J Med Chem 2013;70:579-88.
38. Joshi MC, Wicht KJ, Taylor D, Hunter R, Smith PJ, Egan TJ. In vitro antimalarial activity, β-haematin inhibition and structure activity relationships in a series of quinoline triazoles. Eur J Med Chem 2013;69:338-47.
39. Plech T, Wujec M, Kosikowska U, Malm A, Rajtar B, Polz-Dacewicz M. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids againstdrug-susceptible and drug-resistant bacteria. Eur J Med Chem 2013;60:128-34.
40. Hassan GS, MEl-Messery S, Al-Omary FAM, Al-Rashood ST, Shabayek MI, Abulfadl YS, et al. Nonclassical antifolates, part 4. 5-(2-Aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study. Eur J Med Chem 2013;66:135-45.
41. Raj R, Singh P, Haberkern NT, Faucher RM, Patel N, Land KM, et al. Synthesis of 1H-1,2,3-triazole linked b-lactameisatin bi-functional hybrids and preliminary analysis of in vitro activity against the protozoal parasite Trichomonas vaginalis. Eur J Med Chem 2013;63:897-906.
42. Lau LF, Schachter JB, Seymour PA, Sanner MA. Tau protein phosphorylation as a pherapeutic parget in Alzheimer’s pisease. Curr Top Med Chem 2002;7:395–415.
43. Tomoko H, Masashi U, Eiichi O, Saito T, Koichi I, Tsuneko U, et al. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract. J Biochem 1995;117(4):741-9.
44. Christopher JH, Mark AS, Christopher BC, Thomas G, Mavis A, John CL, et al. Bioorg Med Chem Lett 2004;14:5521-5.
45. Shiradkar M, Thomas J, Kanase V, Dighe R. Studying synergism of methyl linked cyclohexyl thiophenes with triazole: synthesis and their cdk5/p25 inhibition activity. Eur J Med Chem 2011;46:2066-74.
46. Darandale SN, Mulla NA, Pansare DN, Sangshetti JN, Shinde DB. A novel amalgamation of 1,2,3-triazoles, piperidines and thienopyridine rings and evaluation of their antifungal activity. Eur J Med Chem 2013;65:527-32.
47. Raj R, Singh P, Singh P, Gut J, Rosenthal PJ, Kumar V. Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered-7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation. Eur J Med Chem 2013;62:590-6.
48. Ying-Chao Duan, Yong-Cheng Ma, En Zhang, Xiao-Jing Shi, Meng-Meng Wang, Xian-Wei Ye, Hong-Min Liu, Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Eur J Med Chem 2013;62:11-9.
49. Zhigan Jiang, Yan Wang, Wenya Wang, Shengzheng Wang, Bo Xu, Guorong Fan, et al. Eur J Med Chem 2013;64:16-22.
50. Odlo K, Hentzen J, Dit Chabert JF, Ducki S, Gani OABSM, Sylte I, et al. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4:synthesis, molecular modelling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorg Med Chem 2008;16:4829–38.
51. Sztanke K, Pasternak K, Sidor-Wo´ jtowicz A, skac JT´, Jo´z´wiakd K. Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents. Bioorg Med Chem 2006;14:3635–42.
52. Ezabadi IR, Camoutsis C, Zoumpoulakis P, Geronikaki A, Sokovic M, Glamocˇilijad J, et al. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg Med Chem 2008;16:1150–61.
53. Miyamoto N, Sakai N, Hirayama T, Miwa K, Oguro Y, Oki H, et al. Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Bioorg Med Chem 2013;21:2333–45.
54. Miniyar PB, Mahajan AA, Mokale SN, Shah MU, Kumar AS, Chaturbhuj GU. Triazole hybrids as new type of anti-fungal agents. Arab J Chem 2013;http: //dx. doi. org/10.1016/j. arabjc.2013.09.005.
55. Kaushik CP, Krishan K, Singh SK, Singh D, Saini S. Synthesis and antimicrobial evaluation of 1,4-disubstituted 1,2,3-triazoles with aromatic ester functionality. Arab J Chem 2013 http: //dx. doi. org/10.1016/j. arabjc.2013.09.023.(Article in press).
56. Ibrahim Mohammed A, Hadi Mansour N, Salih Mahdi L. Synthesis and antibacterial activity of 1-N-(β-D-Glucopyranosyl)-4-((1-substituted-1H-1,2,3-triazol-4-yl)ethoxymethyl)-1,2,3-triazoles. Arab J Chem 2014.(Article in press).
57. El-Badih AG. Ghattas A, Moustafa HM, Hassanein EAA, Hussein BRM. Synthesis and antibacterial activity of some new 4-anilino-5-phenyl-4H-1,2,4-triazole-3-thiol derivatives. Arab J Chem 2012. (Article in press).
58. Chetan MB, Ali MI, Ramesh B, Ramu G. Novel pyrimidine and its triazole fused derivatives: synthesis and investigation of antioxidant and anti-inflammatory activity. Arabian J Chem 2011;(Article in press).
59. Mange YJ, Isloor AM, Malladi S, Isloor S, Fun HK. Synthesis and antimicrobial activities of some novel 1,2,4-triazole derivatives. Arab J Chem 2013;6:177–81.
60. Tahlan S, Kumar P, Ramasamy K, Mani V, Kumar Mishra R, Bakar Abdul Majeed A, et al. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of N0-substituted benzylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxopentylidene-4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)benzohydrazides. Arab J Chem 2013;http: //dx. doi. org/10.1016/j. arabjc.2013.07.029. (Article in press).
61. Hunashal RD, Ronad PM, Maddi VS, Satyanarayana D, Kamadod MA. Synthesis, anti-inflammatory and analgesic activity of 2-[4-(substituted benzylideneamino)-5-(substitutedphenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid derivatives. Arab J Chem 2011;http: //dx. doi: 10.1016/j. arabjc.2011.01.003. (Article in press).
62. Hari Narayana Moorthy NS, Vittal UB, Karthikeyan C, Thangapandian V, Venkadachallam AP, Trivedi P. Synthesis, antifungal evaluation and in silico study of novel Schiff bases derived from 4-amino-5-(3,5-dimethoxy-phenyl)-4H-1,2,4-triazol-3-thiol. Arab J Chem 2014;http: //dx. doi. org/10.1016/j. arabjc.2013.12.021. (Article in press).
63. Saundane AR, Manjunatha Y. Synthesis, antimicrobial and antioxidant activities of 2-oxo-6-phenyl-2-yl-4-(20-phenyl-50-substituted 1H-indol-30-yl)-1,2-dihydro pyridin-3-carbonitriles and their derivatives. Arab J Chem 2011;http: //dx. doi: 10.1016/j. arabjc.2011.06.011. (Article in press).
64. Amara S, Othman AA. A convenient new synthesis, characterization and antibacterial activity of double headed acyclo-C-nucleosides from unprotected D-glucose. Arab J Chem 2012;http: //dx. doi. org/10.1016/j. arabjc.2012.05.005. (Article in press).
65. zlem Gu rsoy-Kol O, Ayazog lu E. Antioxidant activities and acidic properties of some novel 4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives, Arab J Chem 2014;http: //dx. doi. org/10.1016/j. arabjc.2013.11.015. (Article in press).
66. Sunil D, Isloor AM, Shetty P, Satyamoorthy K, Prasad ASB. 6-[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl] [1,2,4]triazolo[3,4-b][1,3,4]-thidiazole as a potent antioxidant and an anticancer agent induces growth inhibition followed by apoptosis in HepG2 cells. Arab J Chem 2010;3:211–7.
Statistics
624 Views | 3631 Downloads
How to Cite
Arshad, M. “AN INSIGHT TO THE SYNTHETICALLY OBTAINED TRIAZOLE POSSESSING NUMEROUS BIOLOGICAL ACTIVITIES”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 6, no. 9, 1, pp. 16-23, https://innovareacademics.in/journals/index.php/ijpps/article/view/1277.
Section
Review Article(s)